Physician profile
Daniel K Brown
NPI 1730280165
$5,360.90
in general payments reported to CMS, 2019-2025
30 companies · $502 in 2025
The $502 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $547 · 2020: $322 · 2021: $1,047 · 2022: $1,281 · 2023: $1,089 · 2024: $573 · 2025: $502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,087 · Education: $76.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,086.75 |
| Education | $76.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,997.70 | 2019-2025 | Rinvoq, Skyrizi, Linzess |
| Janssen Biotech, INC. | $614.05 | 2019-2025 | Tremfya, Stelara |
| Medtronic, INC. | $480.21 | 2021-2025 | Interstim, Manoscan, Gi Genius |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $279.46 | 2019-2023 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $269.81 | 2019-2022 | |
| Boston Scientific Corporation | $177.77 | 2019-2023 | Watchman |
| W. L. Gore & Associates, INC. | $162.23 | 2023 | Gore Tag Thoracic Branch Endoprosthesis |
| Ferring Pharmaceuticals INC. | $143.19 | 2019-2022 | |
| Pfizer INC. | $140.02 | 2024-2025 | |
| Lemaitre Vascular, INC. | $105.47 | 2023 | Artegraft Vascular Graft |
| Inari Medical, INC. | $96.28 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Intercept Pharmaceuticals, INC. | $91.45 | 2019-2022 | |
| Surmodics, INC. | $87.82 | 2024 | Pounce Thrombectomy System, Pounce Thrombectomy, Sublime 014 Rx Pta Balloon Dilatation Catheter |
| Celgene Corporation | $85.93 | 2022-2023 | Zeposia |
| Mauna Kea Technologies, INC. | $83.31 | 2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $78.18 | 2023 | Vistaseal, Evarrest, Surgiflo Hemostatic Matrix |
| Amgen INC. | $61.82 | 2020-2022 | |
| Aimmune Therapeutics, INC. | $58.55 | 2024 | |
| Ipsen Biopharmaceuticals, INC | $44.10 | 2025 | Iqirvo |
| Nestle Healthcare Nutrition INC. | $43.11 | 2021-2022 | |
| Enterra Medical, INC. | $39.91 | 2022-2024 | |
| Evoke Pharma, INC. | $35.40 | 2022-2025 | |
| Gilead Sciences, INC. | $35.17 | 2022 | |
| Merck Sharp & Dohme LLC | $34.91 | 2021 | |
| Braintree Laboratories, INC. | $26.33 | 2020 | |
| Redhill Biopharma INC. | $21.44 | 2021 | |
| Lilly USA, LLC | $19.82 | 2025 | Omvoh |
| Micro-Tech Endoscopy USA, INC. | $17.93 | 2025 | |
| Ardelyx, INC. | $16.04 | 2022 | |
| Phathom Pharmaceuticals, INC. | $13.49 | 2024 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.